Carsten‐Oliver Schulz

Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment

Ulrike Heider, Martin Kaiser, Christian Müller et al. · European Journal Of Haematology · 2006 · 171 citations

Medicine, Pharmacology, Pharmacotherapy +17

Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer

Hongyu Liu, Chuanbing Zang, Anna Emde et al. · European Journal of Pharmacology · 2008 · 131 citations

Medicine, Oncology, Pharmacology +12

Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.

Hongyu Liu, Christian Schölz, Chuanbing Zang et al. · PubMed · 2012 · 101 citations

Life Sciences, Oncology, Pharmacology +17

Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients

Uta Brunnberg, Michael Möhr, Richard Noppeney et al. · Annals of Oncology · 2011 · 46 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial

Peter Schmid, J. Krocker, C. Jehn et al. · Annals of Oncology · 2005 · 38 citations

Medicine, Oncology, Pharmacology +11